|
TRIM44 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22369999999705E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.69120000027246E-07 |
| Normal-vs-Stage2 |
3.243800E-02 |
| Normal-vs-Stage3 |
1.629730E-02 |
| Normal-vs-Stage4 |
4.17240000000207E-05 |
| Stage1-vs-Stage2 |
5.071400E-01 |
| Stage1-vs-Stage3 |
2.845800E-01 |
| Stage1-vs-Stage4 |
3.139600E-01 |
| Stage2-vs-Stage3 |
8.452200E-01 |
| Stage2-vs-Stage4 |
2.278800E-01 |
| Stage3-vs-Stage4 |
1.260380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3647000000061E-06 |
| Normal-vs-AfricanAmerican |
6.23069999999837E-05 |
| Normal-vs-Asian |
1.249820E-02 |
| Caucasian-vs-AfricanAmerican |
8.973400E-01 |
| Caucasian-vs-Asian |
7.738600E-01 |
| AfricanAmerican-vs-Asian |
7.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.33879999495579E-08 |
| Normal-vs-Female |
4.185900E-02 |
| Male-vs-Female |
2.884500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.33829999999724E-05 |
| Normal-vs-Extreme_Weight |
1.43180001188625E-09 |
| Normal-vs-Obese |
1.936380E-03 |
| Normal-vs-Extreme_Obese |
7.764200E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.581950E-01 |
| Normal_Weight-vs-Obese |
2.437200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.671000E-01 |
| Extreme_Weight-vs-Obese |
4.182300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.099000E-01 |
| Obese-vs-Extreme_Obese |
3.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.289000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.601370E-04 |
| Normal-vs-Age(61-80Yrs) |
4.14089999956069E-07 |
| Normal-vs-Age(81-100Yrs) |
1.165330E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.133400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.197600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.192440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.392300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.453200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.61030000001006E-07 |
| Normal-VS-Type2 PRCC |
9.628000E-04 |
| Normal-VS-KIRP CIMP |
6.939800E-01 |
| Normal-VS-Unclassified PRCC |
2.076200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.922100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.717590E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.375600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.699160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.358400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.451400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13760000000729E-06 |
| Normal-vs-N1 |
5.135500E-02 |
| Normal-vs-N2 |
7.076100E-03 |
| N0-vs-N1 |
9.486300E-02 |
| N0-vs-N2 |
6.759200E-01 |
| N1-vs-N2 |
3.152200E-01 |
|
|
